Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients with inborn errors of immunity (IEI) showed a similar infection-fatality rate, a lower incidence in pediatric age, and a younger age at death than the SARS-CoV-2–positive Italian population. The fatality rate was lower than previously reported from other IEI cohorts. Antibody deficiencies showed a long-lasting SARS-CoV-2 positivity.
Milito, C., Lougaris, V., Giardino, G., Punziano, A., Vultaggio, A., Carrabba, M., et al. (2021). Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. IN PRACTICE, 9(7), 2904-2906 [10.1016/j.jaip.2021.04.017].
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity
Cancrini C;Aiuti A;
2021-01-01
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive patients with inborn errors of immunity (IEI) showed a similar infection-fatality rate, a lower incidence in pediatric age, and a younger age at death than the SARS-CoV-2–positive Italian population. The fatality rate was lower than previously reported from other IEI cohorts. Antibody deficiencies showed a long-lasting SARS-CoV-2 positivity.| File | Dimensione | Formato | |
|---|---|---|---|
|
Elsevier 2.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
530.25 kB
Formato
Adobe PDF
|
530.25 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
